PAPER Lee EK, Kim HH, Kuwano Y, Abdelmohsen K, Srikantan S, Subaran SS, Gleichmann M, Mughal MR, Martindale JL, Yang X, Worley PF, Mattson MP, Gorospe M
SEARCH RESULTS
331009 RESULTS
PAPER Sun H, Jiang YJ, Yu QS, Luo CC, Zou JW
The effect of Li+ on GSK-3 inhibition: molecular dynamics simulation.
J Mol Model. 2011 Feb;17(2):377-81. PubMed: 20473698PAPER Filippov AV, Gröbner G, Antzutkin ON
Aggregation of amyloid Abeta((1-40)) peptide in perdeuterated 2,2,2-trifluoroethanol caused by ultrasound sonication.
Magn Reson Chem. 2010 Jun;48(6):427-34. PubMed: 20474020PAPER Kakizawa T, Hidaka K, Hamada D, Yamaguchi R, Uemura T, Kitamura H, Tagad HD, Hamada T, Ziora Z, Hamada Y, Kimura T, Kiso Y
Tetrapeptides, as small-sized peptidic inhibitors; synthesis and their inhibitory activity against BACE1.
J Pept Sci. 2010 Jun;16(6):257-62. PubMed: 20474036PAPER Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, Oh W, Yang YS, Suh JG, Lee BH, Jin HK, Bae JS
Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.
Neurobiol Aging. 2012 Mar;33(3):588-602. PubMed: 20471717PAPER Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O'Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging.
Neurobiol Aging. 2010 Aug;31(8):1275-83. PubMed: 20472326PAPER Chalbot S, Zetterberg H, Blennow K, Fladby T, Grundke-Iqbal I, Iqbal K
Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.
Neurosci Lett. 2010 Jul 12;478(3):179-83. PubMed: 20470866PAPER Foley P
Lipids in Alzheimer's disease: A century-old story.
Biochim Biophys Acta. 2010 Aug;1801(8):750-3. PubMed: 20471492PAPER Zade D, Beiser A, McGlinchey R, Au R, Seshadri S, Palumbo C, Wolf PA, Decarli C, Milberg W
Interactive effects of apolipoprotein E type 4 genotype and cerebrovascular risk on neuropsychological performance and structural brain changes.
J Stroke Cerebrovasc Dis. 2010 Jul-Aug;19(4):261-8. PubMed: 20471857PAPER Kume K, Hanyu H, Sato T, Hirao K, Kanetaka H, Shimizu S, Sakurai H, Iwamoto T
[Prediction of the development of Alzheimer disease in patients with mild cognitive impairment].
Nihon Ronen Igakkai Zasshi. 2010;47(2):147-52. PubMed: 20472978PAPER Daiello LA, Ott BR, Festa EK, Friedman M, Miller LA, Heindel WC
Effects of cholinesterase inhibitors on visual attention in drivers with Alzheimer disease.
J Clin Psychopharmacol. 2010 Jun;30(3):245-51. PubMed: 20473058PAPER Gong G, Oʼbryant SE
The Arsenic Exposure Hypothesis for Alzheimer Disease.
Alzheimer Dis Assoc Disord. 2010 May 13; PubMed: 20473132PAPER Lee SJ, Kim JS, Yoo JY, Song IU, Kim BS, Jung SL, Yang DW, Kim YI, Jeong DS, Lee KS
Influence of white matter hyperintensities on the cognition of patients with Parkinson disease.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):227-33. PubMed: 20473133PAPER Koric L, Felician O, Guedj E, Hubert AM, Mancini J, Boucraut J, Ceccaldi M
Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease?
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):278-83. PubMed: 20473135PAPER Serrano-Pozo A, Vega GL, Lütjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.
Alzheimer Dis Assoc Disord. 2010 Jul-Sep;24(3):220-6. PubMed: 20473136Current Filters
No filters selected